Results
|
1.
|
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy. MedStar authors:
- Jhaveri, Khushali
- Malkovska, Vera
- Peravali, Monica
- Schlam, Ilana
Year: 2020
Citation: - Blood Advances. 4(23):6019-6022, 2020 Dec 08.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Dahiya S, Holtzman NG, Jhaveri KS, Malkovska V, Peravali M, Rapoport AP, Richardson PK, Schlam I
|
|
2.
|
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx R Digital Spatial Profiler. MedStar authors:
- Schlam, Ilana
- Swain, Sandra M
Year: 2021
Citation: - Cancers. 13(17), 2021 Sep 04.
Institution: - MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- Hematology and Oncology
- MedStar Health
Medline publication type:
All authors: - Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, On Behalf Of The GeoMx Breast Cancer Consortium, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin O, Sato H, Schlam I, Sorlie T, Stover DG, Swain SM, Swarbrick A, Thompson EA, Tolaney SM, Warren SE
|
|
3.
|
Left Ventricular Assist Devices in Patients With Active Malignancies. MedStar authors:
- Barac, Ana
- Basyal, Binaya
- Gallagher, Christopher
- Molina, Ezequiel
- Schlam, Ilana
- Sheikh, Farooq
- Zaghlol, Raja
Year: 2021
Citation: - JACC.CardioOncology. 3(2):305-315, 2021 Jun.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Cardiovascular Disease Fellowship
- Internal Medicine Residency
Medline publication type:
All authors: - Barac A, Basyal B, Cheng RK, Gallagher C, Lee AY, Li S, Mahr C, Molina E, Schlam I, Sheikh FH, Zaghlol R
|
|
4.
|
|
|
5.
|
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study. MedStar authors:
- Lynce, Filipa
- Schlam, Ilana
Year: 2021
Citation: - Journal of Genetic Counseling. 30(2):383-393, 2021 04.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ahn J, Campos C, Denduluri N, Dutil J, Friedman S, Geng X, Graves KD, Isaacs C, Lynce F, Nahleh Z, Peshkin BN, Ricker C, Rodriguez P, Schlam I
|
|
6.
|
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors:
- Chitalia, Ami
- Gallagher, Christopher
- Schlam, Ilana
- Swain, Sandra M
- Tiwari, Shruti
Year: 2023
Citation: - MedRxiv : the Preprint Server for Health Sciences. 2023 Dec 04
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C
|
|
7.
|
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors:
- Chitalia, Ami
- Gallagher, Christopher
- Schlam, Ilana
- Swain, Sandra M
- Tiwari, Shruti
Year: 2024
Citation: - Nature communications . 15(1):2691, 2024 Mar 27.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C
|
|
8.
|
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors:
- Chitalia, Ami
- Gallagher, Christopher
- Schlam, Ilana
- Swain, Sandra M
Year: 2024
Citation: - Nature communications . 15(1):3957, 2024 May 10.
Institution: - MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- Hematology/Oncology
- MedStar Health
Medline publication type:
All authors: - Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C
|